Recent News

Share
Print
and/or

Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
427 News Items found
Q&A
Memorial Sloan Kettering surgeon Prasad Adusumilli
CAR T Cell Therapy Shows Promise for Treating Mesothelioma

A combination immunotherapy approach using CAR T cells could be an effective new way to treat mesothelioma.
MSK radiologist Andreas Wibmer
Brown Fat — Which Warms Babies and Bears — Protects Against Harmful Aspects of Obesity, Study Finds

People with small amounts of brown fat have lower risk of certain obesity-related conditions, according to a retrospective study conducted by researchers at Memorial Sloan Kettering.
Memorial Sloan Kettering immunologist Frederic Geissmann
Feel the Burn: Researchers Identify Fat Storage Protein That Could Be Key to Alleviating Obesity

Researchers discover how immune cells called macrophages regulate whether fat is stored or burned.
MSK cancer biologist Triparna Sen
MSK Scientists Reveal Biology of Shape-Shifting Lung Cancer

Lung cancer has an uncanny ability to change its identity to resist drugs. Researchers are learning what drives these changes.
Feature
Group photo of researchers Michael Berger, Marc Ladanyi, Dana Tsui, Rose Brannon, Ryma Benayed, Ahmet Zehir, and David Klimstra.
How a Cutting-Edge Liquid Biopsy for Cancer Was Created at MSK

MSK-ACCESS, a blood test that can detect mutations in 129 genes related to cancer, has already helped guide the treatment of more than 2,800 patients at MSK.
In the Lab
Physician-scientist Omar Abdel-Wahab
Research Suggests How Boosting Neoantigens Can Make Immunotherapy More Effective

In mice, drugs that change the way proteins are assembled appear to make checkpoint inhibitor drugs work better.
MSK computational biologist Sohrab Shah
Scientists Obtain Real-Time Look at How Cancers Evolve

With the help of machine learning, computational biologists are learning to predict how cancers will evolve.
Finding
Zsofia Stadler
Knowledge of Inherited Gene Mutations Increasingly Can Guide Cancer Treatment

An analysis of patients who received molecular testing at MSK has found that about half of those with hereditary gene mutations could benefit from treatment with therapies that target those alterations.
SKI immunologist Michael Glickman
MSK Scientists Solve One of TB’s Deadliest Tricks

Scientists at Memorial Sloan Kettering have pieced together the biochemical mechanism by which the tuberculosis bacterium sneaks past our immune defenses.
In the Lab
Developmental biologist Luis Parada
Stem Cells May Explain Why Rare Inherited Tumor in Kids Is So Aggressive

Sloan Kettering Institute investigators have found that a subpopulation of cells within a type of sarcoma called malignant peripheral nerve sheath tumor appear to be similar to a type of neural stem cells.